Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

In the phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine conducted in the U.S., Chile, and Peru, anti-spike binding IgG concentration (spike IgG) and pseudovirus 50% neutralizing antibody titer (nAb ID50) measured four weeks after two doses were assessed as correlates of risk and protection aga...

全面介绍

Saved in:

书目详细资料
Main Authors:	David Benkeser, Youyi Fong, Holly Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, Jill Maaske, Tonya Villafana, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Victor Ayala, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Lindsay N. Carpp, April Randhawa, Michele P. Andrasik, James G. Kublin, Margaret Brewinski Isaacs, Mamodikoe Makhene, Tina Tong, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Corey M. Hoffman, Ann R. Falsey, Magdalena E. Sobieszczyk, Richard A. Koup, Rubén O. Donis, Peter B. Gilbert
格式:	Artigo
语言:	英语
出版:	2023
在线阅读:	https://doi.org/10.1038/s41541-023-00630-0 https://www.nature.com/articles/s41541-023-00630-0.pdf
标签:	添加标签没有标签, 成为第一个标记此记录!

因特网

https://doi.org/10.1038/s41541-023-00630-0
https://www.nature.com/articles/s41541-023-00630-0.pdf

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

因特网

相似书籍